Ac immune to present at the svb leerink 11th annual global healthcare conference

Lausanne, switzerland, feb. 02, 2022 (globe newswire) -- ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in a fireside chat and one-on-one investor meetings during the svb leerink 11th annual global healthcare conference, taking place virtually february 14-18, 2022.
ACIU Ratings Summary
ACIU Quant Ranking